Huang Yi-ran
Department of Urology, Renji Hospital of Shanghai Second Medical University, Shanghai 200127, China.
Zhonghua Nan Ke Xue. 2005 Jan;11(1):76-9.
More than one-third of men may experience erectile dysfunction (ED) after nerve-sparing radical retropubic prostatectomy. A recent study has shown that vardenafil, a phosphodiesterase 5 inhibitor, could significantly improve the key indices of erectile function in men after unilateral or bilateral nerve-sparing radical retropubic prostatectomy. Few adverse events were observed in the study.
超过三分之一的男性在保留神经的耻骨后根治性前列腺切除术后可能会出现勃起功能障碍(ED)。最近一项研究表明,磷酸二酯酶5抑制剂伐地那非可显著改善单侧或双侧保留神经的耻骨后根治性前列腺切除术后男性勃起功能的关键指标。该研究中观察到的不良事件较少。